Marquette University

e-Publications@Marquette
Physics Faculty Research and Publications

Physics, Department of

11-1999

Slow-Binding Inhibition of the Aminopeptidase from Aeromonas
proteolytica by Peptide Thiols: Synthesis and Spectroscopic
Characterization
Kristi M. Huntington
The Ohio State University

David L. Bienvenue
Utah State University

Yaoming Wei
The Ohio State University

Brian Bennett
Marquette University, brian.bennett@marquette.edu

Richard C. Holz
Marquette University, richard.holz@marquette.edu

See next page for additional authors

Follow this and additional works at: https://epublications.marquette.edu/physics_fac
Part of the Physics Commons

Recommended Citation
Huntington, Kristi M.; Bienvenue, David L.; Wei, Yaoming; Bennett, Brian; Holz, Richard C.; and Pei, Dehua,
"Slow-Binding Inhibition of the Aminopeptidase from Aeromonas proteolytica by Peptide Thiols: Synthesis
and Spectroscopic Characterization" (1999). Physics Faculty Research and Publications. 44.
https://epublications.marquette.edu/physics_fac/44

Authors
Kristi M. Huntington, David L. Bienvenue, Yaoming Wei, Brian Bennett, Richard C. Holz, and Dehua Pei

This article is available at e-Publications@Marquette: https://epublications.marquette.edu/physics_fac/44

Marquette University

e-Publications@Marquette
Physics Faculty Research and Publications/College of Arts and Sciences
This paper is NOT THE PUBLISHED VERSION; but the author’s final, peer-reviewed manuscript. The
published version may be accessed by following the link in the citation below.

Biochemistry, Vol. 38, No. 47 (1 November 1999): 15587–15596. DOI. This article is © American
Chemical Society Publications and permission has been granted for this version to appear in ePublications@Marquette. American Chemical Society Publications does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from
American Chemical Society Publications.

Slow-Binding Inhibition of the
Aminopeptidase
from Aeromonasproteolytica by Peptide
Thiols: Synthesis and Spectroscopic
Characterization
Kristi M. Huntington
Department of Chemistry and Ohio State Biochemistry Program, The Ohio State University, Columbus,
Ohio

David L. Bienvenue
Department of Chemistry and Biochemistry, Utah State University, Logan, Utah

Yaoming Wei
Department of Chemistry and Ohio State Biochemistry Program, The Ohio State University, Columbus,
Ohio

Brian Bennett
Department of Chemistry and Biochemistry, Utah State University, Logan, Utah

Richard C. Holz
Department of Chemistry and Biochemistry, Utah State University, Logan, Utah

Dehua Pei
Department of Chemistry and Ohio State Biochemistry Program, The Ohio State University, Columbus,
Ohio

SUBJECTS:
Peptides and proteins, Metals, Ions,

Abstract
Peptide-derived thiols of the general structure N-mercaptoacyl-leucyl-p-nitroanilide (1a−c) were synthesized and
found to be potent, slow-binding inhibitors of the aminopeptidase from Aeromonasproteolytica (AAP). The
overall potencies (KI*) of these inhibitors against AAP range from 2.5 to 57 nM exceeding that of the natural
product bestatin and approaching that of amastatin. The corresponding alcohols (2a−b) are simple competitive
inhibitors of much lower potencies (KI = 23 and 360 μM). These data suggest that the free thiols are involved in
the formation of the E·I and E·I* complexes, presumably serving as a metal ligand. To investigate the nature of
the interaction of the thiol-based inhibitors with the dinuclear active site of AAP, we have recorded electronic
absorption and EPR spectra of Co(II)Co(II)-, Co(II)Zn(II)-, and Zn(II)Co(II)-AAP in the presence of the strongest
binding inhibitor, 1c. Both [CoZn(AAP)] and [ZnCo(AAP)], in the presence of 1c, exhibited an absorption band
centered at 320 nm characteristic of an S → Co(II) ligand−metal charge-transfer band. In addition, absorption
spectra recorded between 400 and 700 nm showed changes characteristic of 1c interacting with each active-site
metal ion. EPR spectra recorded at high temperature (19 K) and low power (2.5 mW) indicated that in a given
enzyme molecule, 1c interacts weakly with one of the metal ions in the dinuclear site and that the
crystallographically identified μ-OH(H) bridge, which has been shown to mediate electronic interaction of the
Co(II) ions, is likely broken upon 1c binding. EPR spectra of [CoCo(AAP)]-1c, [ZnCo(AAP)]-1c, and [CoZn(AAP)]1c were also recorded at lower temperature (3.5−4.0 K) and high microwave power (50−553 mW). The observed
signals were unusual and appeared to contain, in addition to the incompletely saturated contributions from the
signals characterized at 19 K, a very sharp feature at geff ≈ 6.8 that is characteristic of thiolate-Co(II) interactions.
These data suggest that the thiolate moiety can bind to either of the metal ions in the dinuclear active site of
AAP but does not bridge the dinuclear cluster. Compounds 1a−c are readily accessible by synthesis and thus
provide a novel class of potent aminopeptidase inhibitors.

Aminopeptidases are a group of exopeptidases that catalyze the hydrolysis of a wide range of N-terminal amino
acid residues from proteins and polypeptides (1−3). These enzymes are widely distributed in bacteria, yeast,
plant, and animal tissues and, therefore, have a wide variety of biological functions such as protein maturation,
protein degradation, hormone level regulation, and cell-cycle control (3). The importance of understanding the
mechanism of action of aminopeptidases is underscored by the recent observation that the naturally occurring
peptide analogue inhibitor, bestatin, was shown to significantly decrease HIV viral load in men by inhibiting
leucine aminopeptidase activity (4). Abnormal aminopeptidase activity has also been associated with many

health conditions and pathologies including aging, cataracts, inflammation, cystic fibrosis, cancer, and leukemia;
thus, their biological and medicinal significance is immense (1−3). In addition, recent studies on the biochemical
pathways involved in metastasis have revealed a set of proteinases and genes that play important roles in tumor
growth and proliferation (5, 6). Aminopeptidase activity has been reported on the surface of tumor cells (7),
suggesting that aminopeptidases play essential roles in the metastatic process, particularly in the steps involving
tumor cells traversing the basement membrane and collagenous stroma. A recent study has shown that several
naturally occurring aminopeptidase inhibitors (i.e., bestatin, leuhistin, and actinonin) inhibit matrix degradation
and invasion of extracellular matrixes by fibrosarcoma cells (8). Another role for aminopeptidases in tumor cell
growth involves angiogenesis, the formation of new blood vessels, which is essential for tumor growth (9).
Recently, the type-2 methionine aminopeptidase (MetAP) from eukaryotes has been identified as the molecular
target for the anti-angiogenesis drugs ovalicin and fumagillin (9−13). Thus, the inhibition of aminopeptidase
activity in viruses and at malignant tumors is critically important in preventing the growth and proliferation of
these types of cells and, for this reason, have become the subject of intense efforts in inhibitor design.
The aminopeptidase from the marine bacterium Aeromonas proteolytica (AAP)1 possesses ideal properties for
studying hydrolytic reactions catalyzed by metallo-aminopeptidases (14). AAP is a small, monomeric enzyme
(29 500 Da) that contains two Zn(II) ions per mole of polypeptide and is thermostable for several hours at 70 °C
(14). It has been crystallographically characterized and contains a (μ-aqua)(μ-carboxylato)dizinc(II) core with a
single histidine and carboxylate residue at each metal site (15). Substitution of the two Zn(II) ions with Co(II),
Cu(II), or Ni(II) provides enzymes that are hyperactive by 7.7, 6.5, and 25 times, respectively, toward certain
substrates (16−18). Bennett and Holz (19) recently demonstrated that metal binding to apo-AAP occurs in a
sequential fashion, highlighting the potential formation of heterodimetallic sites. Catalytically competent
heterodimetallic centers provide systems in which the function of each metal ion can be independently studied
by labeling the metal-binding sites with spectroscopically active and silent metal ions, respectively. Several
inhibitors of AAP have been studied in this way, and these molecules can be classified into three types:
substrate analogues, tetrahedral transition-state analogues, and simple metal-chelating agents. Examples of the
former two types include boronic acids (20−22), chloromethyl ketones (14), and phosphonic acids (23−25).
Among the metal chelators, hydroxamates (26−28) and α-hydroxyamides (14) have been shown to be
particularly potent inhibitors of AAP. However, despite the wide-spread use of thiols in designing
metalloenzyme inhibitors (29−31), the use of thiols as aminopeptidase inhibitors is rare (32−34). Here we report
that peptide-derived thiols are potent, slow-binding inhibitors of AAP. Spectroscopic characterization of the
AAP-inhibited complexes reveal that peptide thiols interact with each active-site metal ion.

Materials and Methods
Materials.
4-Mercaptobutyric acid was purchased from Karl Industries Inc. (Aurora, OH). Hepes buffer, l-Leucyl pnitroanalide (Leu-pNA), and cobalt chloride were purchased from Sigma. Zinc sulfate was from J. T. Baker. Tris(2carboxyethyl)phosphine hydrochloride (TCEP) was purchased from Boehringer Mannheim Laboratories. All other
reagents used in this work were purchased from either Aldrich or Sigma.

Inhibitor Synthesis.
All of the coupling reactions between acids and Leu-pNA were carried out with O-benzotriazol-1-yl-N,N,N‘,N‘tetramethyluronium hexafluorophosphate (HBTU) except for 3-methoxypropionic acid, which was coupled to
Leu-pNA with dicyclohexylcarbodiimide (DCC). Products were purified by silica gel or a combination of silica gel
and alumina columns. The commercial 4-mercaptobutytic acid contained a large amount of thiolactone and the
oxidized disulfide dimer. The commercial sample was treated with NaOH to open the thiolactone ring, and then
triphenylphosphine was used to reduce the disulfide bond before use. Mercaptoacetic acid was oxidized to its

dimer form with hydrogen peroxide prior to its use in the coupling reaction. 3-Methoxypropionylleucyl-pnitroanilide was treated with BBr3 at 0 °C to cleave the methyl ether bond (35).
N-(Glycolyl)leucyl-p-nitroanilide (2a): 1H NMR (200 MHz, CDCl3) δ 9.60 (s, 1H), 8.06 (d, J = 9.2 Hz, 2H), 7.59 (d, J =
9.2 Hz, 2H), 7.20 (d, J = 7.5 Hz, 1H), 4.62−4.73 (m, 1H), 4.21 (s, 2H), 3.18 (s, 1H), 1.55−1.95 (m, 3H), 0.80−1.10 (m,
6H). MS (FAB) m/z observed, 310 (M + H+); calcd, 309.
N-(3-Hydroxylpropionyl)leucyl-p-nitroanilide (2b): 1H NMR (200 MHz, CDCl3) δ 9.59 (s, 1H), 8.06 (d, J = 9.2 Hz,
2H), 7.61 (d, J = 9.2 Hz, 2H), 6.82 (d, J = 7.6 Hz, 1H), 4.60−4.73 (m, 1H), 3.94 (t, J = 5.2 Hz, 2H), 3.08 (s, 1H),
2.47−2.60 (t, J = 5.5 Hz, 3H), 1.50−1.90 (m, 3H), 0.80−1.06 (m, 6H). MS (FAB) m/z observed, 324 (M + H+); calcd,
323.
2,2‘-Dithiobis(N-acetylleucyl-p-nitroanilide) (dimer of 1a): 1H NMR (200 MHz, DMSO) δ 10.73 (s, 1H), 8.44 (d, J =
7.5 Hz, 1H), 8.21 (d, J = 9.2 Hz, 2H), 7.84 (d, J = 9.2 Hz, 2H), 4.35−4.58 (m, 1H), 3.56 (d, J = 2.7 Hz, 2H), 1.40−1.80
(m, 3H), 0.80−0.99 (m, 6H). MS (FAB) m/z observed, 649 (M + H+); calcd, 648.
N-(3-Mercaptopropionyl)leucyl-p-nitroanilide (1b): 1H NMR (250 MHz, CDCl3) δ 9.55 (s, 1H), 8.08 (d, J = 9.2 Hz,
2H), 7.61 (d, J = 9.2 Hz, 2H), 6.44 (d, J = 7.9 Hz, 1H), 4.60−4.79 (m, 1H), 2.72−2.95 (m, 2H), 2.50−2.72 (m, 2H),
1.54−1.93 (m, 4H), 0.80−1.12 (m, 6H). MS (FAB) m/z observed, 340 (M + H+); calcd, 339.
N-(4-Mercaptobutyryl)leucyl-p-nitroanilide (1c): 1H NMR (300 MHz, CDCl3) δ 9.46 (s, 1H), 8.00−8.19 (m, 2H),
7.53−7.77 (m, 2H), 6.15 (d, J = 7.9 Hz, 1H), 4.52−4.75 (m, 1H), 2.25−2.72 (m, 4H), 1.98 (t, J = 8.2 Hz, 1H),
1.55−1.90 (m, 5H), 0.83−1.10 (m, 6H). MS (FAB) m/z observed, 354 (M + H+); calcd, 353.
N-(4-Mercaptobutyryl)leucylanilide (1d): 1H NMR (250 MHz, CDCl3) δ 9.44 (s, 1H), 7.52 (d, J = 8.2 Hz, 2H), 7.22
(t, J = 7.9 Hz, 2H), 7.07 (t, J = 7.4 Hz, 1H), 4.81 (m, 1H), 3.50 (m, 1H), 2.62 (t, J = 7.1 Hz, 2H), 2.20−2.50 (m, 2H),
1.60−2.00 (m, 5H), 1.01 (d, J = 5.5 Hz, 3H), 0.97 (d, J = 5.5 Hz, 3H).

Purification of AAP.
The aminopeptidase from A. proteolytica was purified from a stock culture kindly provided by Professor Céline
Schalk (36). Cultures were grown according to the previously published procedure (14) with minor modifications
to the growth media (37). Enzyme was purified as previously described (19). Purified enzyme was stored at −80
°C until needed.

Spectrophotometric Assay of AAP.
AAP activity was measured by the method of Prescott and Wilkes (14) as modified by Baker et al. (21). In this
assay, the hydrolysis of 0.5 mM Leu-pNA (in 50 mM Hepes, pH 7.5, 50 mM NaCl, 100 μM ZnSO4, and 1 mM TCEP)
was measured spectrophotometrically at 25 °C by monitoring the formation of p-nitroaniline. The extent of
hydrolysis was calculated by monitoring the increase in absorbance at 405 nm (Δε405 value of p-nitroaniline of
10 800 M-1 cm-1) (38). One unit was defined as the amount of enzyme that releases 1 μmol of p-nitroaniline at 25
°C in 60 s. The specific activity of purified AAP was typically found to be 120 units/mg of enzyme. This value is
identical to that reported by Prescott and Wilkes (14). Enzyme concentrations were determined from the
absorbance at 278 nm with the value ε278 = 41 800 M-1 cm-1 (39). TCEP (final 1 mM) was added to all assay
reactions in order to keep the peptide thiols in the reduced form; this concentration of TCEP had no effect on
AAP activity or stability.

Slow Binding Inhibition of AAP by Thiol Inhibitors 1a−d.
Inhibitors 1a−d were freshly dissolved in 60:40 MeOH/water (v/v) to give 0.1−1 mM stock solutions. Their
concentrations (1a−c) were determined by hydrolyzing the p-nitroanilide group to completion with 1 N NaOH
and quantitating the released p-nitroaniline at 405 nm. Prior to use, 10 mM TCEP was added to the stock

solution to reduce any disulfide which might have formed during storage (1a was synthesized as the disulfide
linked dimer). Assays were carried out in 50 mM Hepes, pH 7.5, 50 mM NaCl, 100 μM ZnSO4, 1 mM TCEP, and
appropriate concentrations of the inhibitors (0−14 μM) with 500 μM leucyl-p-nitroanilide (Leu-pNA) as
substrate. To determine the equilibrium constants KI and KI*, the reaction was initiated by the addition of AAP
(83−140 ng/mL) to the above mixture and the release of p-nitroaniline was monitored at 405 nm in a PerkinElmer UV−vis spectrophotometer (none of the inhibitors act as substrate of AAP). The initial rate v0 and the
steady-state rate vs were determined by fitting the data against eq 1

Abs = 𝑣s 𝑡 + (𝑣0 − 𝑣s )(1 − e−𝑘𝑡 )/𝑘
(1)
where k is the observed first-order rate constant for the isomerization of the weak complex to the tight complex
at a particular concentration (40). A secondary plot of v0 vs [I] gave the dissociation constant KI according to eq 2

𝑣0 = 𝑉 ⋅ [S]/(𝐾M (1 + [I]/𝐾I ) + [S])
(2)
where V is maximum velocity and KM is the Michaelis constant (40). A similar plot of vs vs [I] gave the dissociation
constant KI*.
To determine the dissociation rate constant k6, AAP (320 nM) was preincubated for 1 h at 0 °C in the presence
of 1a−d (10 μM final concentration). This preincubated enzyme was then used to initiate the reaction by adding
it to a reaction mixture containing 50 mM Hepes, pH 7.5, 50 mM NaCl, 100 μM ZnSO4, 1 mM TCEP, and 500 μM
Leu-pNA. The recovered AAP activity was monitored at 405 nm and the absorbance vs time data were fit to the
eq 3:

Abs = 𝑣𝑠 [𝑡 − (1 − 𝑒 𝑘6 𝑡 )/𝑘6 ]
(3)
Competitive Inhibition by Hydroxy Inhibitors 2a,b. All assays were carried out in 50 mM Hepes, pH 7.5, 50 mM
NaCl, and 100 μM ZnSO4 using Leu-pNA as substrate (20−320 μM) in the presence of 0−400 μM inhibitor (total
volume of 1.0 mL). The reaction was initiated by the addition of AAP (83−140 ng) to the reaction mixture and pnitroaniline formation was monitored as before over 5 min. The initial rates were calculated from the early
regions of the reaction progress curves and then plotted against substrate concentration, from which the
apparent Michaelis constant, K‘M, was determined. The inhibition constant Ki was obtained by plotting K‘M vs [I]
and fitting the data against eq 4:

′
𝐾M
= 𝐾M (1 + [I]/𝐾I )
(4)
Co(II)-Substituted AAP Samples. [CoCo(AAP)], [CoZn(AAP)], and [ZnCo(AAP)] were prepared from the purified
enzyme by a method similar to that of Prescott et al. (17) and Bennett and Holz (41). AAP was dialyzed for 72 h
at 4 °C against 10 mM 1,10-phenanthroline monohydrochloride in 50 mM Hepes buffer (pH 7.5) and then
exhaustively dialyzed against chelex-treated Hepes buffer. Metal insertion was effected by direct addition, with
efficient mixing, of 1 equiv of MCl2 (where M = Co or Zn; ≥ 99.999% CoCl2, Strem Chemicals, Newburyport,
Massachusetts; 99.999% ZnCl2, Aldrich) followed by a 30 min incubation period at 20−25 °C. The second metal
was then inserted in the same manner, and the electronic absorption spectrum recorded. The inhibitor 1c (20 μL

of a 10 mM stock solution + TCEP) was introduced onto the side-wall of an anaerobic cuvette, and the enzyme
sample introduced. As earlier work has demonstrated by optical methods (42), violently flicking the above
system facilitates rapid and efficient mixing of the reagents.
Spectroscopic Measurements. All spectrophotometric measurements were performed on a Shimadzu UV3101PC spectrophotometer equipped with a constant temperature holder and a Haake (Type 423) constant
temperature circulating bath. The use of 200 μL, 1 cm path-length microcuvettes (QS, Hellma) sealed with a
rubber septa, facilitated the recording of the optical spectra under anaerobic conditions. Subtraction of the
absorption spectrum of apo-AAP from those of substituted enzyme samples, was performed using Shimadzu UV3101 software. Enzyme concentrations for electronic absorption studies were typically 1 mM. Low-temperature
dual mode EPR spectroscopy was carried out as in earlier work (19, 41) using a Bruker ESP-300E spectrometer
equipped with an ER 4116 DM dual mode X-band cavity and an Oxford Instruments ESR-900 helium flow
cryostat. EPR spectra were recorded at a modulation frequency of 100 kHz with microwave frequencies of about
9.65 and 9.37 GHz for perpendicular and parallel mode, respectively. Precise microwave frequencies were
recorded for individual spectra to ensure exact g-alignment and all spectra are presented with respect to the
magnetic field range corresponding to a microwave frequency of 9.646000 GHz. Other EPR recording
parameters are specified in the figure legend. EPR simulations were carried out as in earlier work (19, 41). All
buffers for spectroscopic samples contained 20% 2-propanol to prevent aggregation at high protein
concentrations. Purified enzyme stored for up to 2 weeks at 4 °C in Hepes buffer, pH 7.5, containing 20% (v/v) 2propanol, showed no measurable decrease in activity. Comparison of electronic absorption and EPR spectra with
those recorded on more dilute samples in the absence of 2-propanol indicated that 2-propanol had no effect on
the electronic structure of the dinuclear metal center (43).

Results
Slow-Binding Inhibition of AAP.
Peptide thiols of the general structure of 1 (Figure 1) were synthesized and found to be potent, time-dependent
inhibitors of AAP. Upon careful examination, inhibitors 1a−d resulted in biphasic curves when the hydrolysis of
leucyl-p-nitroanilide by AAP was monitored in a continuous fashion, indicative of slow-binding inhibition (Figure
2) (40). The inhibition kinetics can be described by the following equilibria,

𝑘5
𝐾I
E + I⇌ E•I ⇌ E•I∗
𝑘6
where KI is the equilibrium inhibition constant for the formation of the initial complex, E·I, and k5 and k6 are the
forward and reverse rate constants for the slow conversion of the initial E·I complex into a tight complex E·I*,
respectively. The overall potency of the slow-binding inhibitors is described by the overall equilibrium
constant, KI* = KIk6/(k5 + k6). Table 1 lists the inhibition constants for thiols 1a−d as well as the corresponding
alcohols (2a,b). Thiol inhibitors 1a−c have similar KI values (200−260 nM) as well as similar forward rate
constants, k5 (3.0−5.4 min-1). However, the overall potency (KI*) differs significantly, with 1c (KI* = 2.5 nM) being
∼16-fold more potent than 1a or 1b. This is primarily due to the difference in their k6 values (0.066 min1
for 1c vs ∼0.9 min-1 for 1a,b). This suggests that 1a−c bind to AAP with similar rates but the dissociation
of 1c from the enzyme active site is an order of magnitude slower than that of 1a or 1b. Inhibitor 1d, which is
structurally similar to 1c but does not contain the p-nitro group, is 25-fold less potent than 1c (KI* = 63 nM
for 1d). This is primarily due to the 10-fold increase in the KI value (1970 nM for 1d vs 210 nM for 1c). The
corresponding alcohols (2a,b) are simple competitive inhibitors and are much poorer inhibitors (KI = 23 and 340
μM for 2a and 2b, respectively) (Figure 3). These data suggest that the p-nitro group is important for the

formation of the E·I complex, whereas the free thiol is involved in the formation of both E·I and E·I* complexes,
presumably serving as a metal ligand. As a comparison, we also determined the inhibition constant for bestatin,
a known slow-binding inhibitor of AAP (46), under the assay conditions used for 1a−d. A KI* value of 10 ± 1 nM
was obtained, in agreement with the value (18 nM) reported by Wilkes and Prescott (46). The extremely slow
binding kinetics of bestatin made it difficult to determine the KI, k5, and k6 values (46).

Figure 1 Structures of AAP inhibitors.

Figure 2 Slow-binding inhibition of AAP by peptide thiols 1a−c. (A) Reaction progress for the hydrolysis of LeupNA (500 μM) in 50 mM Hepes, pH 7.5, 50 mM NaCl, 1 mM TCEP, and 100 μM ZnSO4 and in the presence of the
indicated concentrations of 1c. The reaction was initiated by the addition of 0.01 unit of AAP (0.083 μg) as the
last component. (B) Reactivation of AAP that had been treated with inhibitors 1a−c. AAP (320 nM) was
incubated with excess 1a−c (10 μM) for 1 h at 0 °C. At time zero, 100 μL of the preincubated AAP/inhibitor
complex was used to initiate the hydrolysis of Leu-pNA (700 μM for 1a and 500 μM for 1b and 1c) under the
same conditions as in panel A. The first-order rate constant k6 was determined by fitting the data to the
following equation: Abs = νs[t − 1/k6(1 − e-k6t)].

Figure 3 Double reciprocal plot velocity (1/V) vs substrate concentration 1/[S] in the presence of varying
inhibitor 2a concentrations.
Table 1: Kinetic Constants for AAP Inhibition by Peptide Thiolsa
inhibitor KI (nM)
KI* (nM) k5 (min-1) k6 (min-1)
1a
200 ± 76
40 ± 10 3.0 ± 1.3 0.76 ± 0.07
1b
260 ± 17
57 ± 3
3.5 ± 0.4 0.98 ± 0.16
1c
210 ± 17
2.5 ± 0.3 5.4 ± 1.5 0.066 ± 0.016
1d
1970 ± 170
63 ± 4
1.7 ± 0.3 0.055 ± 0.004
2a
23300 ± 4300
2b
360000 ± 37000
bestatin ND
10 ± 1
ND
ND
a
Data reported are the mean ± SD for three or more independent experiments. ND, not determined.

Electronic Absorption Spectra of 1c Bound to [CoCo(AAP)], [CoZn(AAP)], and
[CoZn(AAP)].
Since 1c is the most potent inhibitor of those tested, its mechanism of inhibition was investigated by electronic
absorption spectroscopy using cobalt-substituted AAP. Electronic absorption spectra of [CoZn(AAP)]-1c and
[ZnCo(AAP)]-1c were recorded in the 250−400 nm range. Both Co(II)-substituted AAP enzymes exhibited an
absorption band centered at 320 nm in the presence of inhibitor 1c. Unfortunately, the free ligand (1c) also
showed a strong absorption (ε ≈ 14 200 M-1 cm-1) due to the p-nitroanilide group. Our attempts to perform the
same experiment with 1d, which lacks the p-nitroanilide group, also failed because of the low aqueous solubility
of 1d. Subtraction of the free ligand absorption from that of [CoZn(AAP)]-1c or [ZnCo(AAP)]-1c shows an
increase in absorption at 320 nm over that of free enzyme (Figure 4). This absorption band is very characteristic
of an S → Co(II) ligand-to-metal charge-transfer (LMCT) band. As a control, an aqueous sample of Co(II) + 1c in
50 mM Hepes at pH 7.5 was recorded (Figure 4, inset). These data indicate that, in the absence of enzyme, the S
→ Co(II) LMCT band is observed at ∼360 nm. Therefore, the absorption band observed at 320 nm, in each of the
AAP samples with 1c present, is likely due to a Co(II)-S−thiolate interaction.

Figure 4 Electronic absorption spectra of free AAP and AAP−1c complex (after subtraction of the free ligand
absorbance). Dotted line, [CoZn(AAP)]-1c; dashed lined, [ZnCo(AAP)]-1c; solid line, [ZnZn(AAP)] alone.
[ZnZn(AAP)], [ZnCo(AAP)], [CoZn(AAP)], and [CoCo(AAP)] all have the same spectrum at 300−350 nm region.
Inset: Co(II) + 1c in 50 mM Hepes (pH 7.5) (dotted line) and Co(II) alone (solid line).
Electronic absorption spectra of [CoCo(AAP)], [CoZn(AAP)], and [ZnCo(AAP)] were also recorded in the 400−750
nm region and were identical to those previously reported for these species (17, 19, 41). The absorption due to
apo-AAP was subtracted in all cases. The absorption spectrum of [CoCo(AAP)] (Figure 5) shows an absorption
maximum of 525 nm and a molar absorptivity (ε) of ∼85 M-1 cm-1. Addition of 1c to [CoCo(AAP)] resulted in a
marked change in the optical absorption spectrum (Figure 5). There was a clear shift in λmax from 525 to ∼570
nm and an increase in the absorption coefficient from 85 to 270 M-1 cm-1. Furthermore, the spectrum of
[CoCo(AAP)]-1c exhibited fine structure that comprises at least three absorption bands at 548, 583, and 606 nm.
Similar spectral changes were also observed when inhibitor 1a or l-leucinethiol (44) was added to [CoCo(AAP)].
The increase in the absorption coefficient and the appearance of fine structure is an indication that the
geometry around one or both of the Co(II) ions is significantly altered upon inhibitor binding and demonstrates
the direct interaction of 1c with the dinuclear active site of AAP.

Figure 5 Electronic absorption spectrum of [CoCo(AAP)] in the absence (dashed line) and presence (solid line) of
2 equiv of 1c.
To ascertain the nature of the geometrical change observed for [CoCo(AAP)] upon binding 1c, electronic
absorption spectra of [CoZn(AAP)] and [ZnCo(AAP)] to which 1c had been added were recorded (Figure 6). The
absorption coefficient of [CoCo(AAP)] (85 M-1 cm-1) is essentially the sum of the absorption coefficients of

[CoZn(AAP)] (58 M-1 cm-1; Figure 6A) and [ZnCo(AAP)] (29 M-1 cm-1; Figure 6B) and thus indicates that the
individual Co(II) ions in [CoZn(AAP)] and [ZnCo(AAP)] must adopt very similar coordination geometries in their
respective substituted enzyme forms as they do in the dinuclear center of [CoCo(AAP)]. The electronic
absorption spectrum of [CoZn(AAP)] is consistent with the Co(II) ion in the first metal-binding site adopting a
distorted five-coordinate geometry. On the basis of its low molar absorptivity, the Co(II) ion in the second metalbinding site likely adopts a distorted octahedral or pentacoordinate geometry. Upon the addition of 1c to
[CoZn(AAP)], the absorption coefficient nearly quadrupled to 198 M-1 cm-1 and the λmax exhibited the same redshift as that observed for [CoCo(AAP)] (i.e., 525 to ∼570 nm) (Figure 6A). The spectrum also exhibited a similar
fine structure pattern to that of 1c bound to [CoCo(AAP)]. On the other hand, the addition of 1c to [ZnCo(AAP)]
decreased λmax from 525 to 510 nm, but the molar absorptivity increased from 30 to 97 M-1 cm-1 (Figure 6B).
These data indicate that the changes observed in the absorption spectrum of [CoCo(AAP)]-1c are primarily due
to inhibitor binding to the first metal-binding site; however, 1c also interacts with the second Co(II) ion.

Figure 6 (A) Electronic absorption spectrum of [CoZn(AAP)] in the absence (dashed line) and presence (solid line)
of 2 equiv of 1c. (B) Electronic absorption spectrum of [ZnCo(AAP)] in the absence (dashed line) and presence
(solid line) of 2 equiv of 1c.

EPR Spectroscopy of Co(II)-Substituted AAP Complexes with 1c.
EPR spectra of [Co(AAP)], [CoCo(AAP)], [CoZn(AAP)], and [ZnCo(AAP)] have been recorded previously and are
well characterized (19, 41). In the present study, EPR spectra were recorded on the various Co(II)-substituted
forms of AAP (i.e., [CoCo(AAP)], [ZnCo(AAP)], and [CoZn(AAP)]) in the presence of 1c (Figure 7). In each case, two
distinct EPR spectra were observed depending on the EPR running conditions. At relatively high temperatures
(18−20 K) and modest microwave powers (0.5−2.0 mW), [ZnCo(AAP)] and [CoZn(AAP)] exhibited spectra similar,
though not identical to those observed for the uncomplexed forms of the enzyme. For instance, [ZnCo(AAP)]
shows a broad, relatively featureless spectrum at 18.5 K, 0.8 mW (Figure 7e) with a barely detectable 7.2 mT
hyperfine pattern centered around geff ≈ 6.9. The spectrum of the [CoZn(AAP)] complex with 1c (Figure 7g) at
19.5 K, 2.5 mW, differs from that of the resting signal in that a higher proportion of the hyperfine split signal is
observed in the spectrum of the complex. However, the 7.2 mT splitting centered at geff ≈ 6.92 and
the g2 feature at geff ≈ 2.74 are similar to the corresponding geff values for the resting enzyme signal of 6.88 and
2.75, respectively. These data establish that in at least some proportion of the enzyme molecules, a weak
interaction of 1c occurs with one of the metal ions, which is sufficient to perturb, but not drastically alter, its
resting enzyme EPR signal.

Figure 7 EPR Spectra of cobalt-substituted forms of AAP upon addition of inhibitor 1c. (a) 5 mM CoCl2, 20 mM
inhibitor 1c, recorded at 3.9 K, 50 mW microwave power; (b) [CoCo(AAP)] + 1c, 4 K, 50 mW; (c) [CoCo(AAP)] + 1c,
19 K, 0.64 mW; (d) [ZnCo(AAP)] + 1c, 3.5 K, 50 mW; (e) [ZnCo(AAP)] + 1c, 18.5 K, 0.8 mW; (f) [CoZn(AAP)] + 1c, 4
K, 50 mW; (g) [CoZn(AAP)] + 1c, 19.5 K, 2.5 mW. All samples were buffered with 50 mM Hepes buffer, pH 7.5. All
spectra were recorded using 100 kHz modulation frequency, 1.26 mT modulation amplitude, 3.2 mT s-1 field
sweep rate and 164 ms time constant.
Further information about the nature of the interaction of 1c with AAP comes from examination of the EPR
spectrum of [CoCo(AAP)]-1c recorded at 19 K, 0.64 mW microwave power (Figure 7c). Whereas the hightemperature, low-power signals from [ZnCo(AAP)] and [CoZn(AAP)] exhibited some perturbation upon the
addition of 1c, the signal from [CoCo(AAP)] bears no resemblance to that of uncomplexed [CoCo(AAP)] and
instead resembles that of [Co(AAP)] (19). This implies that a bridging moiety between the cobalt ions, which was
proposed to be the μ-OH(H) bridge (15, 19), is lost upon the binding of 1c with the dinuclear active site. The
signal from [CoCo(AAP)]-1c is not identical to that of native [Co(AAP)]; in particular, the 7.4 mT splitting pattern
is observed at a very high geff of 7.3. This, in conjunction with the derivative g2 feature at 2.54 and the g3 feature
at about 1.8, suggests an E/D value of ∼0.33 compared to 0.28 for [Co(AAP)]. These data imply that both Co(II)binding sites in AAP are perturbed upon the binding of 1c.
The high-temperature, low-power EPR data from [CoCo(AAP)]-1c, [ZnCo(AAP)]-1c, and [CoZn(AAP)]-1c indicate
that in a given enzyme molecule, 1c interacts with one of the metal ions in the dinuclear site and that the
crystallographically identified μ-OH(H) bridge, which has been shown to mediate electronic interaction of the
Co(II) ions (19), is broken. The quite subtle changes seen in the EPR spectra compared to those exhibited by
isolated Co(II) ions in the uncomplexed forms of the enzyme do not suggest, however, that the interaction which
gives rise to the distorted high-temperature, low-power EPR spectra involves direct binding of 1c via the thiol
group. This suggested the possibility that the second metal ion may interact with 1c through the thiol group
yielding a species that does not exhibit an EPR spectrum at high temperatures. We therefore reexamined the

EPR samples at lower temperature (3.5−4.0 K) and high microwave power (50 mW) and spectra of [CoCo(AAP)]1c, [ZnCo(AAP)]-1c, and [CoZn(AAP)]-1c recorded under these conditions are presented as traces b, d, and f in
Figure 7. For all three samples, the signals consist of a sharp spike at geff = 6.82 for [CoZn(AAP)] and 6.30 for
[CoCo(AAP)] and [ZnCo(AAP)], with a broad underlying absorption. In all cases, the broad absorption resembles
the corresponding high-temperature signal. On the basis of these data, it could not be ascertained whether
additional features associated with the geff = 6.82 or 6.30 signals were also present along with the incompletely
saturated components of the signals characterized at high temperature. Microwave powers of up to 553 mW
were employed in an attempt to selectively saturate features not associated with the geff = 6.82 or 6.30 signals.
However, severe line-shape distortion at such high powers rendered assignments unreliable.
The observed signals at low temperature could be due to one of two spin states. Where a single feature at geff ≈
6.8 or 6.3 is observed, it is often assumed that the signal corresponds to the g1 feature of an Ms = |± 3/2〉
transition where E/D ≈ 0. For an Ms = |±3/2〉 transition, as E/D → 0, so g2 and g3 → 0, and the transition
probabilities for these resonances also approach zero. Computer simulation (Figure 8b) of a species
with geff(1,2,3) = 6.31, 0.055, 0.054, corresponding to Ms = |± 3/2〉, greal ≈ 2.2 and E/D ≈ 0, provides a good model
for the spectrum of the [CoCo(AAP)]-1c complex (Figure 8a) if one assumes the broad absorption from 100 to
550 mT is due solely to incomplete saturation of the other species (Figure 7c). The adoption of an Ms = |±3/2〉
ground-state implies a reversal in the sign of the zero-field splitting parameter, Δ, which in turn implies a large
change in bonding for the Co(II) ion. A second possible origin of this species also exists, however, it is not often
considered. Features in the EPR spectrum, particularly the higher field (lower g) resonances, due to a high-spin
Co(II) ion, in which the paramagnetic electron experiences highly anisotropic coupling to the I = 7/2 59Co nucleus,
can appear as a weak and very broad asymmetric signal if the A tensor has only a small projection on that
particular principal g component. A simulation (Figure 8d) for the spectrum of the [CoCo(AAP)]-1c complex could
thus be obtained assuming geff(1,2,3) = 6.31, 3.0, 2.1, corresponding to Ms = |±1/2〉, greal ≈ 2.5 and E/D ≈ 0.25,
including an anisotropic coupling A(1,2,3) = 3.0, 0.0, 1.0 mT. This Ms = |±1/2〉 simulation reproduced the g = 6.3
feature equally as well as the Ms = |±3/2〉 model; however, the presence of weak, broad features in the
experimental spectrum of Figure 7b, underlying the residual absorption due to the high-temperature species of
Figure 7c, has to be assumed. In contrast, assuming an isotropic A tensor yielded a simulation (Figure 8c) in
which the prominence of the g2 and g3 features preclude this model. The absolute magnitudes of the
principal A values were not found to be very critical in determining the distribution of intensities of the various
features in the simulated spectrum, but their relative values were important. Anisotropy of the hyperfine
coupling could arise due to direct binding of a ligand atom such as sulfur onto which extensive electron
delocalization could occur.

Figure 8 Theoretical models for the origin of the g = ∼6.8 or 6.3 feature in the EPR spectra of Co(II)-substituted
AAP-1c complexes. (a) EPR spectrum of [CoCo(AAP)]-1c recorded at 4 K, 50 mW. The sample was buffered with

50 mM Hepes buffer, pH 7.5. The spectrum was recorded using 100 kHz modulation frequency, 1.26 mT
modulation amplitude, 3.2 mT s-1 field sweep rate and 164 ms time constant; (b) theoretical spectrum generated
assuming Ms = |±3/2〉; geff(1,2,3) = 6.30, 0.055, 0.054; AI=7/2 (59Co) = 0, 0, 0 mT. Simulations assuming either
𝐼=7/2
isotropic or anisotropic A(59Co) with a range of principal hyperfine coupling constants 𝐴(1,2,3) (59Co) = ≤3, ≤3, ≤3
mT were essentially indistinguishable; (c) theoretical spectrum generated assuming Ms = |±1/2〉; geff(1,2,3) =
6.30, 3.00, 1.90; AI=7/2 (59Co) = 3.0, 3.0, 3.0 mT; (d), theoretical spectrum generated assuming Ms = |±1/2〉
; geff(1,2,3) = 6.30, 3.00, 1.90; AI=7/2 (59Co) = 3.0, 0, 1.0 mT. Line width and g-strain parameters were identical for the
theoretical spectra b, c, and d.

Figure 9 Proposed binding scheme of 1c with the dinuclear active site of AAP.

Discussion
Because of the important physiological roles that aminopeptidases play, our laboratories have been interested
in designing highly potent inhibitors for this class of enzymes that can function as both mechanistic probes and
potential therapeutic agents. For AAP, several classes of relatively potent inhibitors have previously been
investigated, including the natural products amastatin (KI = 0.26 nM) and bestatin (KI = 10 nM), leucine
halomethyl ketones (KI = 200−700 nM), 1-butaneboronic acid (KI = 9600 nM), d-leucine hydroxamic acid (KI = 2.0
nM), and l-leucinephosphonic acid (KI = 6600 nM) (14, 20−28, 45−48). A common feature of these inhibitors is
that they all contain hydrophobic side chains and potential ligands that can coordinate to the metal ions of AAP.
Crystallographic studies on the d-iodophenylalanine hydroxamate complex of AAP indicates that the
hydroxamate is directly bound to both metal ions in the active site of AAP (49). Since thiols are known to be
good ligands for Zn(II) cations (50), we synthesized N-mercaptoacyl-leucyl-p-nitroanilide, in anticipation that the
N-terminal thiol would ligate to one or both of the Zn(II) ions in the AAP active site. Indeed, peptide
thiols 1a−c prove to be excellent inhibitors of AAP, with potencies (KI = 2.5 nM for 1c) exceeding that of the
natural product bestatin and approaching that of amastatin. As compounds 1a−c are readily accessible by
synthesis, they provide a new class of potent AAP inhibitors that are also useful for investigating the catalytic
mechanisms of aminopeptidases.
Inspection of the observed electronic absorption spectra of [CoCo(AAP)]-1c, [CoZn(AAP)]-1c, and [ZnCo(AAP)]1c indicates that 1c interacts with both metal ions. Ligand-field theory predicts that d−d transitions of four
coordinate Co(II) complexes give rise to intense absorption (ε > 300 M-1 cm-1) in the higher wavelength region of
625 ± 50 nm owing to a comparatively smaller ligand-field stabilization energy, while transitions of octahedral
Co(II) complexes have very weak absorption (ε < 30 M-1 cm-1) at lower wavelengths (525 ± 50 nm) (51). A fivecoordinate Co(II) shows intermediate features: i.e., moderate absorption intensities (50 < ε < 250 M-1 cm-1) with
several maxima between 525 and 625 nm (51, 52). Upon the addition of one equivalent of 1c, [CoCo(AAP)],
[CoZn(AAP)], and [ZnCo(AAP)] give absorption spectra that are very similar to that of the cobalt-substituted

angiotensin converting enzyme in the presence of HSAc−Phe-Ala (542, 610, 634 nm, ε ≈ 350, 520, 520 M-1 cm-1)
(53), AAP in the presence of l-leucinethiol (570 nm, ε ≈ 230 M-1 cm-1 with shoulders at 505, 560, and 618 nm)
(44), and to those of Co(II)-substituted β-lactamase's from Bacillus cereus and Bacteroides fragilis (530 nm, ε ≈
300 M-1 cm-1, with shoulders at 510, 551, 610, 630 nm), which contain a Cys residue as one of the metal ligands
(54, 55). All of these enzymes have been proposed to contain five-coordinate Co(II) centers. On the basis of
these data, the Co(II) ion in [CoZn(AAP)]-1c is likely five-coordinate whereas the Co(II) ion in [ZnCo(AAP)] appears
to also reside in a five-coordinate site but a very distorted octahedral geometry cannot be discounted.
Therefore, it is likely that distortion of each of the Co(II) ions ligand sphere is the cause of a modest change in
the electronic structure rather than a change in coordination number. The distortion of both Co(II) ions
electronic geometries from complexation by a thiol group is consistent with the observed optical spectral
changes.
The EPR spectra observed at g ≈ 6.8 or 6.3 for each Co(II)-substituted AAP complex of 1c are striking in that they
bear no resemblance to any Co(II) EPR signals observed thus far from Co(II)-substituted AAP and its inhibited
complexes (19, 24, 41). The other striking feature of the observed spectra is that they are all similar to each
other. This implies that reaction of 1c with Co(II) in either of the two sites of the dinuclear center yields
electronically similar species. Such a marked change in the EPR signals from those of the Co(II) ions in
uncomplexed species of Co(II)-substituted AAP is due to a large perturbation of the electronic structure. Binding
of the transition-state analogue inhibitor l-leucinephosphonic acid, which provides an η-1,2-μ-phosphonate
bridge between the metal ions and an amine ligand to the second metal ion, has been shown to constrain the
geometries around the Co(II) ions and to lead to delocalization of some 30% of the paramagnetic electron
density from the amine-liganded Co(II) ion (24). Nevertheless, the electronic geometry is not sufficiently
perturbed as to result in any drastic change in the geff and greal values for the hyperfine split species observed in
the Co(II)-substituted AAP-l-leucinephosphonic acid complexes compared to those exhibited by uncomplexed
Co(II)-substituted enzyme forms. Thus, the low-temperature species observed upon the addition of 1c to Co(II)substituted AAP are highly unlikely to arise as a result of an induced change in active-site geometry alone. We,
therefore, propose that the novel signals seen at low temperature are the result of direct sulfur ligation of 1c to
both Co(II) ions in the enzyme active site (Figure 9). In support of this proposal, the spectra of a Co(II)substituted AAP species in the presence of the inhibitors l-leucinethiol and the corresponding alcohol were
recently reported (44). These data revealed that l-leucinethiol elicits analogous low-temperature signals to 1c,
whereas l-leucinol does not, though leucinol does perturb the EPR signals.
Both the Ms = |±3/2〉 and Ms = |±1/2〉 systems described as models for the g ≈ 6.8 or 6.3 EPR signals could
arise as a result of direct sulfur ligation to a Co(II) ion and, thus, analysis of the EPR spectra supports our
proposal that 1c binds to both of the metal ions via the thiol group. At present, there is no definitive way to
discriminate between the two models; however, the Ms = |±1/2〉 model invokes broad features of low intensity
in the spectra for which there is no evidence. Therefore, the Ms = |±3/2〉 model is favored at this time. The
observation of a geff = 6.8 or 6.3 EPR signal upon 1c binding to Co(II)-substituted forms of AAP at low
temperature and, of perturbed EPR spectra at high-temperature suggests that 1c does not discriminate between
the two metal ions. Thus, it appears that 1c can bind to either of the metal ions through the thiol group. Steric
hindrance presumably prevents a second molecule of 1c from reacting at the active site as well as another
functional group on the 1c molecule to bind to the second metal ion.
Combination of the electronic absorption and EPR data indicates that 1c perturbs the electronic structure of
both metal ions in the dinuclear active site of AAP. Moreover, these data clearly show that in a given population
of enzyme, a gross change in electronic structure occurs in both metal ions. The EPR spectra of [CoCo(AAP)] also
indicates that the Co−OH(H)−Co bridge is broken upon reaction with 1c. Because the electronic structure of both
metal ions is altered and because the Co−OH(H)-Co bridge is broken, it is tempting to propose that the thiol

functionality of 1c serves to replace the μ-OH(H) bridge and binds to form a Co−S(R)−Co moiety. However, the
EPR data is not consistent with such a scenario. While one of the metal ions clearly undergoes a large electronic
reorganization, consistent with sulfur ligation, the remaining metal ions display electronic symmetries not unlike
those of the analogous, magnetically isolated Co(II) ions in the respective uncomplexed enzyme species. In
systems of low symmetry, such as [CoCo(AAP)], [CoZn(AAP)], and [ZnCo(AAP)], significant changes in the
electronic properties of the S = 3/2 high-spin Co(II) ions are predicted. The observation that one of the Co(II) ions
in all of the 1c-complexed species of AAP studied retained an EPR signal indicative of low electronic symmetry,
which was only slightly perturbed from the analogous species in the respective resting enzyme, strongly argues
against sulfur ligation to both divalent metal ions via a μ-S(R) bridge. In addition, the spin−spin interaction seen
in resting [CoCo(AAP)] is abolished upon the addition of 1c, and thus, it is unlikely that a single atom bridge is
retained or established. Moreover, the lack of any decrease in the 59Co hyperfine splitting in the signals
observed at high temperature (19 K) upon addition of 1c indicates that there is no significant electron
delocalization from one of the two active-site metal ions.
Perhaps the most intriguing aspect of the complexation of 1c by AAP is the slow rate of reaction. The two metal
ions in AAP have been shown to be electronically distinct (19, 24, 41, 56, 57), and in the slow reaction with 1c,
one would expect that a preference for one or the other metal ion would be exhibited. Both the EPR and optical
data, however, clearly indicate that either, but not both, of the metal ions can bind 1c via the thiol functionality
simultaneously (Figure 9). This implies a lack of exchangeability of the sulfur ligand once bound to the metal,
entirely consistent with the very low inhibition constant of 1c. The slow binding process observed for thiol
containing inhibitors may, therefore, involve the nonselective coordination of the thiol moiety to one of the
metal ions, followed by the slow deprotonation of the thiol group. Glu151 has been implicated as a general base
in the catalytic reaction since it forms a hydrogen bond to the bridging water/(OH-) group in the resting enzyme;
this residue may be responsible for the formation of the thiolate ion (15). The reverse process, dissociation of
the E·I* complex, would require protonation of the thiolate group. The lack of selectivity of 1c for a particular
metal ion will severely hamper X-ray crystallographic investigations of the precise mode of binding of 1c to the
two metal ions in AAP. Future work will, therefore, require inhibitors that contain functionalities that interact
with the substrate-binding pocket in a manner that is sufficiently specific as to uniquely orient the reactive thiol
moiety toward one metal ion.
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